[{"id":"32f1738a-21d7-4891-9595-6f600389e107","acronym":"","url":"https://clinicaltrials.gov/study/NCT05105815","created_at":"2021-11-03T12:53:09.731Z","updated_at":"2024-07-02T16:36:21.578Z","phase":"Phase 1","brief_title":"Safety and Efficacy of Autoimmune Cell Therapy for Patients With Hepatocellular Carcinoma","source_id_and_acronym":"NCT05105815","lead_sponsor":"Huashan Hospital","biomarkers":" HLA-A","pipe":" | ","alterations":" HLA-A*02","tags":["HLA-A"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HLA-A*02"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IPM001"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 23","initiation":"Initiation: 12/31/2021","start_date":" 12/31/2021","primary_txt":" Primary completion: 12/31/2023","primary_completion_date":" 12/31/2023","study_txt":" Completion: 12/31/2024","study_completion_date":" 12/31/2024","last_update_posted":"2021-11-03"}]